Methods and compositions for treating polycystic ovary syndrome
US11858932B2 · kind B2 · utility
2Cited by
9References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2023 |
| Grant date | Jan 2, 2024 |
| Priority date | — |
| Expiry date | Jun 13, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4985
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Polycystic ovary syndrome (PCOS) is characterized by elevated levels of androgens, cysts in the ovaries, and irregular periods. Women with PCOS present with additional symptoms, including hirsutism, alopecia, acne, infertility, weight gain, fatigue, depression and mood changes. The present disclosure provides new compounds, salts, compositions and uses thereof in the treatment of PCOS due to elevated adrenal androgens. Further, the present disclosure provides methods for treating PCOS due to elevated adrenal androgens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.